• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees




FDA- GBCA & NSF Core Presentation (pdf)







Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance


Bayer- Magnevist (Gadopentetate Dimeglumine) Core Presentation (pdf)


Bayer- Eovist (Gadoxetate Disodium) Core Presentation (pdf)




Bracco Diagnostics Inc


Bracco- Prohance (Gadoteridol) Injection Core Presentation (pdf)


Bracco- Multihance (Gadobenate Dimeglumine) Injection Core Presentation (pdf)




GE Healthcare


GE- Safety of Omniscan (Gadodiamide) Injection for Intravenous Use Core Presentation (pdf)


GE- Safety of Omniscan (Gadodiamide) Injection for Intravenous Use Backup Presentation (pdf)




Covidien Pharmaceuticals


Covidien- Optimark (Gadoversetamide Injection) Core Presentation (pdf)




Lantheus Medical Imaging, Inc


Lantheus- Ablavar Core Presentation (pdf)


Lantheus- Ablavar Backup Presentation (pdf)




Guest Speaker


GUEST- Core Presentation (pdf)






OPH- Core Presentation (pdf)